December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Toni Choueiri: Amazing journey all the way from Ankara to Boston and Back
Dec 1, 2024, 21:24

Toni Choueiri: Amazing journey all the way from Ankara to Boston and Back

Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared a post on LinkedIn by Jame Abraham, Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic, adding:

“Amazing journey all the way from Ankara to Boston and Back!

Congratulations Yüksel Ürün and kudos for Jame Abraham, M.D. FACP and The ASCO Post for highlighting this winner!”

Quoting Jame Abraham’s post:

“Amazing journey of Yüksel Ürün. True example of persistence and hard work.”

Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, shared Toni Choueiri’s post, adding:

“I am so honored to have done the LDP program with Yüksel Ürün, who is not only a great oncologist but also an amazing human being and friend!”

Toni Choueiri: Amazing journey all the way from Ankara to Boston and Back

More posts featuring Toni Choueiri,

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Jame Abraham, MD, FACP, is Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic and a Professor of Medicine at Cleveland Clinic Lerner College of Medicine. He also is a Deputy Editor at the ASCO Post and Journal of Oncology Practice of ASCO.

Dr. Abraham is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee and holds leadership roles in NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP).

Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.

As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.

Jasmine Kamboj, MD, is a Medical Oncologist and Hematologist at Mayo Clinic, Rochester, where she serves as a community oncologist across Minnesota and Wisconsin. She is ASCO’s appointed liaison to the Medical Society Consortium on Climate and Health and has contributed to ASCO’s Climate Task Force.

Additionally, Dr. Kamboj is a member of ASCO’s Government Relations Committee and has served on ASCO’s Health Equity and Outcomes Committee, Rural Task Force, and Clinical Trials Task Force.